Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1999
12/02/1999CA2328604A1 Compositions and methods of modulating an immune response to an antigen
12/01/1999EP0960204A1 Method and reagents for genetic immunization
12/01/1999EP0960122A1 Myelopeptides and their therapeutic use
12/01/1999EP0960119A1 T cell antigen receptor peptides
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999EP0959905A2 Polysaccharide-peptide-conjugates
12/01/1999EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999EP0959896A2 Human thyrotropin receptor compositions and use thereof
12/01/1999EP0959893A2 Stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
12/01/1999EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999EP0697866B1 High dose formulations
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1236628A Medicinal preparation containing high content of alpha-linolenic acid and its preparing process
12/01/1999CN1236617A Immunosuppressive medicine
12/01/1999CN1046944C Rapamycin derivatives
12/01/1999CN1046939C Fluoroalkoxy-substituted benzamides and their preparing process and use
11/1999
11/30/1999US5994569 Useful in the treatment or prevention of vitamin d dependent disorders and of il-12-dependent autoimmune diseases
11/30/1999US5994549 Piperidine derivatives and process for their production
11/30/1999US5994516 Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999US5994413 Pressing, extraction
11/30/1999US5994396 Nervous system disorders; autoimmune diseases; antiinflammatory agents
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994378 Antiallergens; antiinflammatory agents
11/30/1999US5994376 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
11/30/1999US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999US5994368 Antiallergens, antiinflammatory agents, analgesics
11/30/1999US5994361 Antitumor, anticancer agent
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994326 Using raffinose
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994299 Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5994126 Obtaining dendritic cell precursors from tissue, culturing on a substrate in medium containing colony stimulating factor to obtain proliferating nonadherent mature cells; therapy for juvenile diabetes, autoimmune diseases, multiple sclerosis
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994082 Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
11/30/1999US5993859 Pharmaceutical agents
11/30/1999US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999US5993820 The antigenic sequence is inserted into the ltb molecule by inserting the gene encoding the inhibin fragment into etxb at the unique sma i restriction site.
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993803 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
11/30/1999US5993783 Aerosols
11/30/1999CA2166774C Pharmaceutical composition for immunomodulating and adjuvant treatment
11/25/1999WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999WO1999060128A1 Il-2 selective agonists and antagonists
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999060013A2 Il-6 antagonist peptides
11/25/1999WO1999059980A1 [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059971A1 Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059960A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999WO1999059631A1 Prevention and treatment of hypergastrinemia
11/25/1999WO1999059627A2 Verotoxin b subunit for immunization
11/25/1999WO1999059625A1 Vaccine delivery system
11/25/1999WO1999059624A2 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059615A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059585A1 Compositions for the treatment of hiv and other viral infections
11/25/1999WO1999059557A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999WO1999059541A2 Cyclosporin preparations
11/25/1999WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm)
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999047158A3 Therapeutic chemokine receptor antagonists
11/25/1999WO1999045957A3 Combined vaccine compositions
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999005527A3 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
11/25/1999DE19823097A1 Pharmaceutical comprising an alpha-protein
11/25/1999CA2690399A1 Il-6 antagonist peptides
11/25/1999CA2333921A1 Verotoxin b subunit for immunization
11/25/1999CA2333144A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999CA2332270A1 Cyclosporin preparations
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2329877A1 Compositions for the treatment of hiv and other viral infections
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2328699A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation
11/25/1999CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999CA2328501A1 Prevention and treatment of hypergastrinemia
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/25/1999CA2328057A1 Composition for the induction of a tumour-specific immune response, methods for its production and use of composition for the treatment of neoplasia
11/24/1999EP0959074A2 Substituted pyrazoles as CRF antagonists
11/24/1999EP0958834A1 Peptide immunotherapeutic agent
11/24/1999EP0958829A1 Use of a peptide compound in the treatment of systemic lupus erythematosus
11/24/1999EP0958823A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 1172